HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

Running, not enrolling · Not applicable

Conditions studied: Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma, Malignant Solid Neoplasm, Ovarian Carcinoma, Pancreatic Carcinoma, Prostate Carcinoma

In brief

This clinical trial studies the effectiveness of a web-based cancer education tool called Helping Oncology Patients Explore Genomics (HOPE-Genomics) in improving patient knowledge of personal genomic testing results and cancer and genomics in general. HOPE-Genomics is a web-based education tool that teaches cancer/leukemia patients, and patients who may be at high-risk for developing cancer, about genomic testing and provide patients with information about their own genomic test results. The HOPE-Genomics tool may improve patient's genomic knowledge and quality of patient-centered care. In addition, it may also improve education and care quality for future patients.

Key facts

Study ID

NCT04905082

Run by

City of Hope Medical Center

People needed

465

Starts

2021-12-30

Expected to finish

2026-06-15

Last updated by the study team

2026-03-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Are enrolled in City of Hope (COH) Institutional Review Board (IRB) 07047
• Have a diagnosis of lung, breast, colorectal, pancreatic, ovarian or prostate cancer
• Having somatic, germline or paired somatic/germline sequencing
• Are fluent in English
• Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
• Are >= 18 years old

You may not qualify if…

• Are unable to provide informed consent

Where it is running

• City of Hope Medical Center — Duarte, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.